The estimated Net Worth of D J Paul E Cowan is at least $3.12 Million dollars as of 16 October 2017. D Cowan owns over 100,000 units of Quotient Ltd stock worth over $1,200,233 and over the last 10 years D sold QTNT stock worth over $1,922,771.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
D Cowan QTNT stock SEC Form 4 insiders trading
D has made over 8 trades of the Quotient Ltd stock since 2015, according to the Form 4 filled with the SEC. Most recently D sold 100,000 units of QTNT stock worth $464,000 on 16 October 2017.
The largest trade D's ever made was selling 100,000 units of Quotient Ltd stock on 16 October 2017 worth over $464,000. On average, D trades about 40,035 units every 73 days since 2015. As of 16 October 2017 D still owns at least 3,158,509 units of Quotient Ltd stock.
You can see the complete history of D Cowan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's D Cowan's mailing address?
D's mailing address filed with the SEC is ELIZABETH HOUSE, 9 CASTLE STREET, , ST. HELIER, Y9, JE2 3RT.
Insiders trading at Quotient Ltd
Over the last 11 years, insiders at Quotient Ltd have traded over $5,237,327 worth of Quotient Ltd stock and bought 21,364,813 units worth $72,052,006 . The most active insiders traders include Advisors Llcperceptive Life..., Zubeen Shroff, and L John Wilkerson. On average, Quotient Ltd executives and independent directors trade stock every 15 days with the average trade being worth of $57,203. The most recent stock trade was executed by Catherine Larue on 31 January 2023, trading 438 units of QTNT stock currently worth $166.
What does Quotient Ltd's logo look like?
Complete history of D Cowan stock trades at Quotient Ltd
Quotient Ltd executives and stock owners
Quotient Ltd executives and other stock owners filed with the SEC include:
-
Franz Walt,
Chief Executive Officer, Director -
Edward Farrell,
Chief Operating Officer -
Jeremy Stackawitz,
Chief Commercial Officer -
Peter Buhler,
Chief Financial Officer -
Heino.N.F.M von Prondzynski,
Independent Chairman of the Board -
Frederick Hallsworth,
Independent Director -
Brian McDonough,
Independent Director -
Zubeen Shroff,
Independent Director -
John Wilkerson,
Independent Director -
Catherine Larue,
Independent Director -
Isabelle Buckle,
Independent Director -
Ernest Larnach,
Head - Financial Accounting & Treasury -
Esteban Uriarte,
Chief Manufacturing Operations Officer -
Mohammad El Khoury,
Chief Commercial Officer -
Christian Albrich,
Chief People Officer -
Dr. Christine Ginocchio,
Chief Scientific & Medical Officer -
Dr. Michael Hausmann,
Chief Technology Officer -
Vittoria Bonasso,
Head of Fin., Group Controller & Principal Accounting Officer -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
CEO & Director -
Ernest Larnach,
Head of Financial Accounting & Treasury -
Vittoria Bonasso,
See Remarks -
Roland Boyd,
See Remarks -
Thomas A Bologna,
Director -
Sarah A Oconnor,
Director -
Stephen Unger,
Chief Financial Officer -
Partners V Lp Galen Partner...,
-
Deidre Quotient Biodiagnost...,
-
D J Paul E Cowan,
See Remarks -
Sophie Bechu,
Director -
Advisors Llcperceptive Life...,
-
Christopher J Lindop,
EVP -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
Chief Executive Officer -
Khoury Mohammad El,
Chief Commercial Officer -
Thomas Aebischer,
Director